Prexasertib lactate

(Synonyms: LY2606368 lactate)
37 Cited Publications
Avis client

Based on 37 publication(s) in Google Scholar

Prexasertib lactate (LY2606368 lactate) is the lactate form of Prexasertib (HY-18174). Prexasertib lactate is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib lactate inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib lactate causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib lactate shows potent anti-tumor activity.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • CAS No.: 2781996-46-9
  • Formule: C21H25N7O5
  • Masse moléculaire:455.47
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Prexasertib lactate

More
Customer Validation & Images
Cell Proliferation/Viability AssayWBFlow CytometryIn Vivo Efficacy StudyApoptosis AnalysisRT-PCR
  • WB
  • Flow Cytometry
  • In Vivo Efficacy Study
  • Apoptosis Analysis
  • RT-PCR
  • Cell Proliferation/Viability Assay

Voir tous les produits spécifiques à Isoform Checkpoint Kinase (Chk)

More

Voir tous les produits spécifiques à Isoform DNA/RNA Synthesis

More
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00